Name | H-Glu-Glu-Lys-Leu-Ile-Val-Val-Ala-Phe-OH |
---|---|
Synonyms |
(2S,5S,8S,11S,14S,17S,20S,23S)-23-Amino-17-(4-aminobutyl)-11-[(2S)-2-butanyl]-20-(2-carboxyethyl)-1-{[(1S)-1-carboxy-2-phenylethyl]imino}-1,4,7,10,13,16,19,22-octahydroxy-14-isobutyl-5,8-diisopropyl-2-methyl-3,6,9,12,15,18,21-heptaazahexacosa-3,6,9,12,15,18,21-heptaen-26-oic acid
Benzenepropanoic acid, α-[[(2S,5S,8S,11S,14S,17S,20S,23S)-23-amino-17-(4-aminobutyl)-25-carboxy-20-(2-carboxyethyl)-1,4,7,10,13,16,19,22-octahydroxy-2-methyl-5,8-bis(1-methylethyl)-11-[(1S)-1-meth ylpropyl]-14-(2-methylpropyl)-3,6,9,12,15,18,21-heptaazapentacosa-3,6,9,12,15,18,21-heptaen-1-ylidene]amino]-, (αS)- |
Description | EEKLIVVAF is a pepitide, can be recognized on HLA-B44 by the anti-melanoma cytolytic T-cell (CTL) clone LB33- CTL-159/5[1][2]. |
---|---|
Related Catalog | |
In Vitro | EEKLIVVAF can be recognized by CTL clone on C1RB*4402 and C1R-B*4403 cells, and (45 ng/mL and 160 ng/mL, respectively; 30 min; 20 ℃) shows the ability to compete with a standard peptide for binding to HLA-B*4402 and HLA-B*4403 molecules[1]. |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 1148.7±75.0 °C at 760 mmHg |
Molecular Formula | C50H82N10O14 |
Molecular Weight | 1047.245 |
Flash Point | 648.5±37.1 °C |
Exact Mass | 1046.601196 |
LogP | 9.32 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.596 |